After separation and isolation of the isoflavonoid fraction, we found that this molecule group affected all tested leukemia cell lines, but with greater specificity on CML cells, inhibiting the BCR/Abl expression and oncogenic proteins involved in cancer progression. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.